APO Research
Talk to an analyst

APO RESEARCH · REPORT

IL-17 Targeting Biological Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global IL-17 Targeting Biological Drugs Industry Growth and Trends Forecast to 2032

28 December 202591 pages

Choose your research edition.

Industry ResearchIL-17 Targeting Biological Drugs Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal IL-17 Targeting Biological Drugs Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal IL-17 Targeting Biological Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal IL-17 Targeting Biological Drugs Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal IL-17 Targeting Biological Drugs Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global IL-17 Targeting Biological Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for IL-17 Targeting Biological Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for IL-17 Targeting Biological Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for IL-17 Targeting Biological Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of IL-17 Targeting Biological Drugs include AstraZeneca, DICE Therapeutics, Eli Lilly and Co., Novartis, UCB, Jiangsu Hengrui Medicine, Akesobio and Chongqing Genrix Biopharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global IL-17 Targeting Biological Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The IL-17 Targeting Biological Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global IL-17 Targeting Biological Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to IL-17 Targeting Biological Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global IL-17 Targeting Biological Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

IL-17 Targeting Biological Drugs Market by Company

AstraZeneca

DICE Therapeutics

Eli Lilly and Co.

Novartis

UCB

Jiangsu Hengrui Medicine

Akesobio

Chongqing Genrix Biopharmaceutical

IL-17 Targeting Biological Drugs Segment by Type

Oral

Injection

IL-17 Targeting Biological Drugs Segment by Application

Hospital

Clinic

Other

IL-17 Targeting Biological Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global IL-17 Targeting Biological Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of IL-17 Targeting Biological Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of IL-17 Targeting Biological Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of IL-17 Targeting Biological Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of IL-17 Targeting Biological Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Oral Table 2. Major Company of Injection Table 3. Global IL-17 Targeting Biological Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global IL-17 Targeting Biological Drugs Sales by Type (2021-2026) & (K Units) Table 5. Global IL-17 Targeting Biological Drugs Sales Market Share in Volume by Type (2021-2026) Table 6. Global IL-17 Targeting Biological Drugs Sales by Type (2021-2026) & (US$ Million) Table 7. Global IL-17 Targeting Biological Drugs Sales Market Share in Value by Type (2021-2026) Table 8. Global IL-17 Targeting Biological Drugs Price by Type (2021-2026) & (US$/Unit) Table 9. Global IL-17 Targeting Biological Drugs Sales by Type (2027-2032) & (K Units) Table 10. Global IL-17 Targeting Biological Drugs Sales Market Share in Volume by Type (2027-2032) Table 11. Global IL-17 Targeting Biological Drugs Sales by Type (2027-2032) & (US$ Million) Table 12. Global IL-17 Targeting Biological Drugs Sales Market Share in Value by Type (2027-2032) Table 13. Global IL-17 Targeting Biological Drugs Price by Type (2027-2032) & (US$/Unit) Table 14. North America IL-17 Targeting Biological Drugs Sales by Type (2021-2026) & (K Units) Table 15. North America IL-17 Targeting Biological Drugs Sales by Type (2021-2026) & (US$ Million) Table 16. Europe IL-17 Targeting Biological Drugs Sales by Type (2021-2026) & (K Units) Table 17. Europe IL-17 Targeting Biological Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific IL-17 Targeting Biological Drugs Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific IL-17 Targeting Biological Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America IL-17 Targeting Biological Drugs Sales by Type (2021-2026) & (K Units) Table 21. Latin America IL-17 Targeting Biological Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa IL-17 Targeting Biological Drugs Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa IL-17 Targeting Biological Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. IL-17 Targeting Biological Drugs Industry Trends Table 25. IL-17 Targeting Biological Drugs Industry Drivers Table 26. IL-17 Targeting Biological Drugs Industry Opportunities and Challenges Table 27. IL-17 Targeting Biological Drugs Industry Restraints Table 28. Global IL-17 Targeting Biological Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global IL-17 Targeting Biological Drugs Revenue Market Share by Company (2021-2026) Table 30. Global IL-17 Targeting Biological Drugs Sales by Company (2021-2026) & (K Units) Table 31. Global IL-17 Targeting Biological Drugs Sales Share by Company (2021-2026) Table 32. Global IL-17 Targeting Biological Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global IL-17 Targeting Biological Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global IL-17 Targeting Biological Drugs Major Company Production Sites and Headquarters Table 35. Global IL-17 Targeting Biological Drugs Company, Product Type & Application Table 36. Global IL-17 Targeting Biological Drugs Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global IL-17 Targeting Biological Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global IL-17 Targeting Biological Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global IL-17 Targeting Biological Drugs Sales by Region (2021-2026) & (K Units) Table 41. Global IL-17 Targeting Biological Drugs Sales Market Share in Volume by Region (2021-2026) Table 42. Global IL-17 Targeting Biological Drugs Sales by Region (2021-2026) & (US$ Million) Table 43. Global IL-17 Targeting Biological Drugs Sales Market Share in Value by Region (2021-2026) Table 44. Global IL-17 Targeting Biological Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global IL-17 Targeting Biological Drugs Sales by Region (2027-2032) & (K Units) Table 46. Global IL-17 Targeting Biological Drugs Sales Market Share in Volume by Region (2027-2032) Table 47. Global IL-17 Targeting Biological Drugs Sales by Region (2027-2032) & (US$ Million) Table 48. Global IL-17 Targeting Biological Drugs Sales Market Share in Value by Region (2027-2032) Table 49. Global IL-17 Targeting Biological Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global IL-17 Targeting Biological Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global IL-17 Targeting Biological Drugs Sales by Application (2021-2026) & (K Units) Table 52. Global IL-17 Targeting Biological Drugs Sales Market Share in Volume by Application (2021-2026) Table 53. Global IL-17 Targeting Biological Drugs Sales by Application (2021-2026) & (US$ Million) Table 54. Global IL-17 Targeting Biological Drugs Sales Market Share in Value by Application (2021-2026) Table 55. Global IL-17 Targeting Biological Drugs Price by Application (2021-2026) & (US$/Unit) Table 56. Global IL-17 Targeting Biological Drugs Sales by Application (2027-2032) & (K Units) Table 57. Global IL-17 Targeting Biological Drugs Sales Market Share in Volume by Application (2027-2032) Table 58. Global IL-17 Targeting Biological Drugs Sales by Application (2027-2032) & (US$ Million) Table 59. Global IL-17 Targeting Biological Drugs Sales Market Share in Value by Application (2027-2032) Table 60. Global IL-17 Targeting Biological Drugs Price by Application (2027-2032) & (US$/Unit) Table 61. North America IL-17 Targeting Biological Drugs Sales by Application (2021-2026) & (K Units) Table 62. North America IL-17 Targeting Biological Drugs Sales by Application (2021-2026) & (US$ Million) Table 63. Europe IL-17 Targeting Biological Drugs Sales by Application (2021-2026) & (K Units) Table 64. Europe IL-17 Targeting Biological Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific IL-17 Targeting Biological Drugs Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific IL-17 Targeting Biological Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America IL-17 Targeting Biological Drugs Sales by Application (2021-2026) & (K Units) Table 68. Latin America IL-17 Targeting Biological Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa IL-17 Targeting Biological Drugs Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa IL-17 Targeting Biological Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. AstraZeneca Company Information Table 72. AstraZeneca Business Overview Table 73. AstraZeneca IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. AstraZeneca IL-17 Targeting Biological Drugs Product Portfolio Table 75. AstraZeneca Recent Development Table 76. DICE Therapeutics Company Information Table 77. DICE Therapeutics Business Overview Table 78. DICE Therapeutics IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. DICE Therapeutics IL-17 Targeting Biological Drugs Product Portfolio Table 80. DICE Therapeutics Recent Development Table 81. Eli Lilly and Co. Company Information Table 82. Eli Lilly and Co. Business Overview Table 83. Eli Lilly and Co. IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Eli Lilly and Co. IL-17 Targeting Biological Drugs Product Portfolio Table 85. Eli Lilly and Co. Recent Development Table 86. Novartis Company Information Table 87. Novartis Business Overview Table 88. Novartis IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Novartis IL-17 Targeting Biological Drugs Product Portfolio Table 90. Novartis Recent Development Table 91. UCB Company Information Table 92. UCB Business Overview Table 93. UCB IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. UCB IL-17 Targeting Biological Drugs Product Portfolio Table 95. UCB Recent Development Table 96. Jiangsu Hengrui Medicine Company Information Table 97. Jiangsu Hengrui Medicine Business Overview Table 98. Jiangsu Hengrui Medicine IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Jiangsu Hengrui Medicine IL-17 Targeting Biological Drugs Product Portfolio Table 100. Jiangsu Hengrui Medicine Recent Development Table 101. Akesobio Company Information Table 102. Akesobio Business Overview Table 103. Akesobio IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Akesobio IL-17 Targeting Biological Drugs Product Portfolio Table 105. Akesobio Recent Development Table 106. Chongqing Genrix Biopharmaceutical Company Information Table 107. Chongqing Genrix Biopharmaceutical Business Overview Table 108. Chongqing Genrix Biopharmaceutical IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Chongqing Genrix Biopharmaceutical IL-17 Targeting Biological Drugs Product Portfolio Table 110. Chongqing Genrix Biopharmaceutical Recent Development Table 111. North America IL-17 Targeting Biological Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. North America IL-17 Targeting Biological Drugs Sales by Country (2021-2026) & (K Units) Table 113. North America IL-17 Targeting Biological Drugs Sales Market Share by Country (2021-2026) Table 114. North America IL-17 Targeting Biological Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 115. North America IL-17 Targeting Biological Drugs Sales Market Share Forecast by Country (2027-2032) Table 116. North America IL-17 Targeting Biological Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America IL-17 Targeting Biological Drugs Market Size by Country (2021-2026) & (US$ Million) Table 118. North America IL-17 Targeting Biological Drugs Market Share by Country (2021-2026) Table 119. North America IL-17 Targeting Biological Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America IL-17 Targeting Biological Drugs Market Share Forecast by Country (2027-2032) Table 121. Europe IL-17 Targeting Biological Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Europe IL-17 Targeting Biological Drugs Sales by Country (2021-2026) & (K Units) Table 123. Europe IL-17 Targeting Biological Drugs Sales Market Share by Country (2021-2026) Table 124. Europe IL-17 Targeting Biological Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 125. Europe IL-17 Targeting Biological Drugs Sales Market Share Forecast by Country (2027-2032) Table 126. Europe IL-17 Targeting Biological Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe IL-17 Targeting Biological Drugs Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe IL-17 Targeting Biological Drugs Market Share by Country (2021-2026) Table 129. Europe IL-17 Targeting Biological Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe IL-17 Targeting Biological Drugs Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific IL-17 Targeting Biological Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific IL-17 Targeting Biological Drugs Sales by Country (2021-2026) & (K Units) Table 133. Asia-Pacific IL-17 Targeting Biological Drugs Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific IL-17 Targeting Biological Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 135. Asia-Pacific IL-17 Targeting Biological Drugs Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific IL-17 Targeting Biological Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific IL-17 Targeting Biological Drugs Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific IL-17 Targeting Biological Drugs Market Share by Country (2021-2026) Table 139. Asia-Pacific IL-17 Targeting Biological Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific IL-17 Targeting Biological Drugs Market Share Forecast by Country (2027-2032) Table 141. Latin America IL-17 Targeting Biological Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Latin America IL-17 Targeting Biological Drugs Sales by Country (2021-2026) & (K Units) Table 143. Latin America IL-17 Targeting Biological Drugs Sales Market Share by Country (2021-2026) Table 144. Latin America IL-17 Targeting Biological Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 145. Latin America IL-17 Targeting Biological Drugs Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America IL-17 Targeting Biological Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America IL-17 Targeting Biological Drugs Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America IL-17 Targeting Biological Drugs Market Share by Country (2021-2026) Table 149. Latin America IL-17 Targeting Biological Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America IL-17 Targeting Biological Drugs Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa IL-17 Targeting Biological Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa IL-17 Targeting Biological Drugs Sales by Country (2021-2026) & (K Units) Table 153. Middle East and Africa IL-17 Targeting Biological Drugs Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa IL-17 Targeting Biological Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 155. Middle East and Africa IL-17 Targeting Biological Drugs Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa IL-17 Targeting Biological Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa IL-17 Targeting Biological Drugs Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa IL-17 Targeting Biological Drugs Market Share by Country (2021-2026) Table 159. Middle East and Africa IL-17 Targeting Biological Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa IL-17 Targeting Biological Drugs Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. IL-17 Targeting Biological Drugs Distributors List Table 164. IL-17 Targeting Biological Drugs Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. IL-17 Targeting Biological Drugs Image Figure 2. Global IL-17 Targeting Biological Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global IL-17 Targeting Biological Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global IL-17 Targeting Biological Drugs Sales (2021-2032) & (K Units) Figure 5. Oral Image Figure 6. Global Oral Sales YoY Growth (2021-2032) & (K Units) Figure 7. Injection Image Figure 8. Global Injection Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global IL-17 Targeting Biological Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global IL-17 Targeting Biological Drugs Market Share by Type 2025 VS 2032 Figure 11. North America IL-17 Targeting Biological Drugs Sales Market Share in Volume by Type in 2025 Figure 12. North America IL-17 Targeting Biological Drugs Sales Market Share in Value by Type in 2025 Figure 13. Europe IL-17 Targeting Biological Drugs Sales Market Share in Volume by Type in 2025 Figure 14. Europe IL-17 Targeting Biological Drugs Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific IL-17 Targeting Biological Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific IL-17 Targeting Biological Drugs Sales Market Share in Value by Type in 2025 Figure 17. Latin America IL-17 Targeting Biological Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Latin America IL-17 Targeting Biological Drugs Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa IL-17 Targeting Biological Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa IL-17 Targeting Biological Drugs Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 IL-17 Targeting Biological Drugs Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global IL-17 Targeting Biological Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global IL-17 Targeting Biological Drugs Market Share by Application 2025 VS 2032 Figure 31. North America IL-17 Targeting Biological Drugs Sales Market Share in Volume by Application in 2025 Figure 32. North America IL-17 Targeting Biological Drugs Sales Market Share in Value by Application in 2025 Figure 33. Europe IL-17 Targeting Biological Drugs Sales Market Share in Volume by Application in 2025 Figure 34. Europe IL-17 Targeting Biological Drugs Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific IL-17 Targeting Biological Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific IL-17 Targeting Biological Drugs Sales Market Share in Value by Application in 2025 Figure 37. Latin America IL-17 Targeting Biological Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Latin America IL-17 Targeting Biological Drugs Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa IL-17 Targeting Biological Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa IL-17 Targeting Biological Drugs Sales Market Share in Value by Application in 2025 Figure 41. North America IL-17 Targeting Biological Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America IL-17 Targeting Biological Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America IL-17 Targeting Biological Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America IL-17 Targeting Biological Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe IL-17 Targeting Biological Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe IL-17 Targeting Biological Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe IL-17 Targeting Biological Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe IL-17 Targeting Biological Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific IL-17 Targeting Biological Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific IL-17 Targeting Biological Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific IL-17 Targeting Biological Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific IL-17 Targeting Biological Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America IL-17 Targeting Biological Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America IL-17 Targeting Biological Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America IL-17 Targeting Biological Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America IL-17 Targeting Biological Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa IL-17 Targeting Biological Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa IL-17 Targeting Biological Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa IL-17 Targeting Biological Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa IL-17 Targeting Biological Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. IL-17 Targeting Biological Drugs Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. IL-17 Targeting Biological Drugs Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injection
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • AstraZeneca
  • DICE Therapeutics
  • Eli Lilly and Co.
  • Novartis
  • UCB
  • Jiangsu Hengrui Medicine
  • Akesobio
  • Chongqing Genrix Biopharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global IL-17 Targeting Biological Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global IL-17 Targeting Biological Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 IL-17 Targeting Biological Drugs Market by Type
  6. 1.3.1 Oral
  7. 1.3.2 Injection
  8. 1.4 Global IL-17 Targeting Biological Drugs Market Size by Type
  9. 1.4.1 Global IL-17 Targeting Biological Drugs Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global IL-17 Targeting Biological Drugs Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global IL-17 Targeting Biological Drugs Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America IL-17 Targeting Biological Drugs Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe IL-17 Targeting Biological Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific IL-17 Targeting Biological Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America IL-17 Targeting Biological Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa IL-17 Targeting Biological Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 IL-17 Targeting Biological Drugs Industry Trends
  2. 2.2 IL-17 Targeting Biological Drugs Industry Drivers
  3. 2.3 IL-17 Targeting Biological Drugs Industry Opportunities and Challenges
  4. 2.4 IL-17 Targeting Biological Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by IL-17 Targeting Biological Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by IL-17 Targeting Biological Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by IL-17 Targeting Biological Drugs Price (2021-2026)
  4. 3.4 Global IL-17 Targeting Biological Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global IL-17 Targeting Biological Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global IL-17 Targeting Biological Drugs Company, Product Type & Application
  7. 3.7 Global IL-17 Targeting Biological Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global IL-17 Targeting Biological Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 IL-17 Targeting Biological Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 IL-17 Targeting Biological Drugs Tier 1, Tier 2, and Tier 3
4 IL-17 Targeting Biological Drugs Regional Status and Outlook
  1. 4.1 Global IL-17 Targeting Biological Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global IL-17 Targeting Biological Drugs Historic Market Size by Region
  3. 4.2.1 Global IL-17 Targeting Biological Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global IL-17 Targeting Biological Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global IL-17 Targeting Biological Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global IL-17 Targeting Biological Drugs Forecasted Market Size by Region
  7. 4.3.1 Global IL-17 Targeting Biological Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global IL-17 Targeting Biological Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global IL-17 Targeting Biological Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 IL-17 Targeting Biological Drugs by Application
  1. 5.1 IL-17 Targeting Biological Drugs Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global IL-17 Targeting Biological Drugs Market Size by Application
  6. 5.2.1 Global IL-17 Targeting Biological Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global IL-17 Targeting Biological Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global IL-17 Targeting Biological Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America IL-17 Targeting Biological Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe IL-17 Targeting Biological Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific IL-17 Targeting Biological Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America IL-17 Targeting Biological Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa IL-17 Targeting Biological Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 AstraZeneca
  2. 6.1.1 AstraZeneca Company Information
  3. 6.1.2 AstraZeneca Business Overview
  4. 6.1.3 AstraZeneca IL-17 Targeting Biological Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 AstraZeneca IL-17 Targeting Biological Drugs Product Portfolio
  6. 6.1.5 AstraZeneca Recent Developments
  7. 6.2 DICE Therapeutics
  8. 6.2.1 DICE Therapeutics Company Information
  9. 6.2.2 DICE Therapeutics Business Overview
  10. 6.2.3 DICE Therapeutics IL-17 Targeting Biological Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 DICE Therapeutics IL-17 Targeting Biological Drugs Product Portfolio
  12. 6.2.5 DICE Therapeutics Recent Developments
  13. 6.3 Eli Lilly and Co.
  14. 6.3.1 Eli Lilly and Co. Company Information
  15. 6.3.2 Eli Lilly and Co. Business Overview
  16. 6.3.3 Eli Lilly and Co. IL-17 Targeting Biological Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Eli Lilly and Co. IL-17 Targeting Biological Drugs Product Portfolio
  18. 6.3.5 Eli Lilly and Co. Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis IL-17 Targeting Biological Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Novartis IL-17 Targeting Biological Drugs Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 UCB
  26. 6.5.1 UCB Company Information
  27. 6.5.2 UCB Business Overview
  28. 6.5.3 UCB IL-17 Targeting Biological Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 UCB IL-17 Targeting Biological Drugs Product Portfolio
  30. 6.5.5 UCB Recent Developments
  31. 6.6 Jiangsu Hengrui Medicine
  32. 6.6.1 Jiangsu Hengrui Medicine Company Information
  33. 6.6.2 Jiangsu Hengrui Medicine Business Overview
  34. 6.6.3 Jiangsu Hengrui Medicine IL-17 Targeting Biological Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Jiangsu Hengrui Medicine IL-17 Targeting Biological Drugs Product Portfolio
  36. 6.6.5 Jiangsu Hengrui Medicine Recent Developments
  37. 6.7 Akesobio
  38. 6.7.1 Akesobio Company Information
  39. 6.7.2 Akesobio Business Overview
  40. 6.7.3 Akesobio IL-17 Targeting Biological Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Akesobio IL-17 Targeting Biological Drugs Product Portfolio
  42. 6.7.5 Akesobio Recent Developments
  43. 6.8 Chongqing Genrix Biopharmaceutical
  44. 6.8.1 Chongqing Genrix Biopharmaceutical Company Information
  45. 6.8.2 Chongqing Genrix Biopharmaceutical Business Overview
  46. 6.8.3 Chongqing Genrix Biopharmaceutical IL-17 Targeting Biological Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Chongqing Genrix Biopharmaceutical IL-17 Targeting Biological Drugs Product Portfolio
  48. 6.8.5 Chongqing Genrix Biopharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America IL-17 Targeting Biological Drugs Sales by Country
  2. 7.1.1 North America IL-17 Targeting Biological Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America IL-17 Targeting Biological Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America IL-17 Targeting Biological Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America IL-17 Targeting Biological Drugs Market Size by Country
  6. 7.2.1 North America IL-17 Targeting Biological Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America IL-17 Targeting Biological Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America IL-17 Targeting Biological Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe IL-17 Targeting Biological Drugs Sales by Country
  2. 8.1.1 Europe IL-17 Targeting Biological Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe IL-17 Targeting Biological Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe IL-17 Targeting Biological Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe IL-17 Targeting Biological Drugs Market Size by Country
  6. 8.2.1 Europe IL-17 Targeting Biological Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe IL-17 Targeting Biological Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe IL-17 Targeting Biological Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific IL-17 Targeting Biological Drugs Sales by Country
  2. 9.1.1 Asia-Pacific IL-17 Targeting Biological Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific IL-17 Targeting Biological Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific IL-17 Targeting Biological Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific IL-17 Targeting Biological Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific IL-17 Targeting Biological Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific IL-17 Targeting Biological Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific IL-17 Targeting Biological Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America IL-17 Targeting Biological Drugs Sales by Country
  2. 10.1.1 South America IL-17 Targeting Biological Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America IL-17 Targeting Biological Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America IL-17 Targeting Biological Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America IL-17 Targeting Biological Drugs Market Size by Country
  6. 10.2.1 South America IL-17 Targeting Biological Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America IL-17 Targeting Biological Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America IL-17 Targeting Biological Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa IL-17 Targeting Biological Drugs Sales by Country
  2. 11.1.1 Middle East and Africa IL-17 Targeting Biological Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa IL-17 Targeting Biological Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa IL-17 Targeting Biological Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa IL-17 Targeting Biological Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa IL-17 Targeting Biological Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa IL-17 Targeting Biological Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa IL-17 Targeting Biological Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 IL-17 Targeting Biological Drugs Value Chain Analysis
  2. 12.1.1 IL-17 Targeting Biological Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 IL-17 Targeting Biological Drugs Production Mode & Process
  7. 12.2 IL-17 Targeting Biological Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 IL-17 Targeting Biological Drugs Distributors
  10. 12.2.3 IL-17 Targeting Biological Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst